Ruxolitinib

Ruxolitinib


Ruxolitinib is an orally active, selective JAK1/2 inhibitor that modulates cytokine signaling, suppresses tumor proliferation, and induces toxic mitophagy, with therapeutic potential in myeloproliferative neoplasms and inflammatory conditions.

Molecular structure of the compound BP-44052
    • Unit
    • Price
    • Qty
    • 500 MG
    • $210.00
    • 1 G
    • $350.00
    • 5 G
    • $890.00

Usually ships within 24 hours.


Would you like to inquire about custom quantity?
Inquire